Stocks
Teladoc Health Financial Statements (TDOC) |
||||||||||
| Teladoc Healthsmart-lab.ru | % | 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.03.2021 | 30.09.2021 | 28.02.2022 | 01.03.2023 | 23.02.2024 | 26.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 094 | 2 033 | 2 407 | 2 602 | 2 613 | ||||
| Operating Income, bln rub | -418.2 | -239.0 | 13 198 | -248.6 | -316.1 | |||||
| EBITDA, bln rub | ? | -340.1 | -14.3 | 13 469 | 192.0 | -280.9 | ||||
| Net profit, bln rub | ? | -485.1 | -428.8 | -13 660 | -220.4 | -249.7 | ||||
| OCF, bln rub | ? | -53.5 | 194.0 | 189.3 | 350.0 | 253.5 | ||||
| CAPEX, bln rub | ? | 26.0 | 63.9 | 172.8 | 156.3 | 110.8 | ||||
| FCF, bln rub | ? | -79.6 | 130.1 | 16.5 | 193.7 | 142.7 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 1 121 | 1 621 | 1 890 | 2 053 | 1 431 | |||||
| Cost of production, bln rub | 390.8 | 650.3 | 744.0 | 760.0 | 866.4 | |||||
| R&D, bln rub | 164.9 | 311.9 | 333.6 | 348.5 | 337.0 | |||||
| Interest expenses, bln rub | 60.5 | 80.4 | 9.27 | 22.3 | 31.4 | |||||
| Assets, bln rub | 17 755 | 17 653 | 17 735 | 4 345 | 4 392 | 4 321 | ||||
| Net Assets, bln rub | ? | 15 884 | 15 988 | 16 046 | 2 308 | 2 326 | 2 289 | |||
| Debt, bln rub | 1 465 | 1 297 | 1 267 | 1 573 | 1 592 | 1 590 | ||||
| Cash, bln rub | 786.6 | 826.4 | 896.0 | 918.2 | 1 124 | 1 098 | ||||
| Net debt, bln rub | 678.7 | 470.5 | 371.4 | 655.1 | 468.6 | 492.3 | ||||
| Ordinary share price, rub | 200.0 | 126.8 | 91.8 | 23.7 | 21.6 | 34.9 | ||||
| Number of ordinary shares, mln | 90.5 | 156.9 | 161.5 | 164.6 | 167.7 | |||||
| Market cap, bln rub | 18 098 | 0 | 14 410 | 3 818 | 3 547 | 5 854 | ||||
| EV, bln rub | ? | 18 777 | 470 | 14 782 | 4 474 | 4 015 | 6 346 | |||
| Book value, bln rub | -718 | 1 517 | -369 | -602 | -425 | -399 | ||||
| EPS, rub | ? | -5.36 | -2.73 | -84.6 | -1.34 | -1.49 | ||||
| FCF/share, rub | -0.88 | 0.83 | 0.10 | 1.18 | 0.85 | |||||
| BV/share, rub | -7.94 | -2.35 | -3.73 | -2.58 | -2.38 | |||||
| EBITDA margin, % | ? | -31.1% | -0.70% | 559.6% | 7.38% | -10.7% | ||||
| Net margin, % | ? | -44.3% | -21.1% | -567.5% | -8.47% | -9.56% | ||||
| FCF yield, % | ? | -0.44% | 0.00% | 0.90% | 0.43% | 5.46% | 2.44% | |||
| ROE, % | ? | -3.05% | 0.00% | -2.67% | -591.9% | -9.47% | -10.9% | |||
| ROA, % | ? | -2.73% | 0.00% | -2.42% | -314.3% | -5.02% | -5.78% | |||
| P/E | ? | -37.3 | -33.6 | -0.28 | -16.1 | -23.4 | ||||
| P/FCF | -227.5 | 110.8 | 231.0 | 18.3 | 41.0 | |||||
| P/S | ? | 16.5 | 7.09 | 1.59 | 1.36 | 2.24 | ||||
| P/BV | ? | -25.2 | 0.00 | -39.1 | -6.34 | -8.35 | -14.7 | |||
| EV/EBITDA | ? | -55.2 | -1 035 | 0.33 | 20.9 | -22.6 | ||||
| Debt/EBITDA | -2.00 | -26.0 | 0.05 | 2.44 | -1.75 | |||||
| R&D/CAPEX, % | 633.4% | 487.8% | 193.1% | 222.9% | 304.1% | |||||
| CAPEX/Revenue, % | 2.38% | 3.15% | 7.18% | 6.01% | 4.24% | |||||
| Teladoc Health shareholders | ||||||||||
